Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
08/10/26	HK$0.2160	+6.93%	24,000
07/10/26	HK$0.2020	-2.42%	102,000
06/10/26	HK$0.2070	-2.82%	6,000
05/10/26	HK$0.2130	-1.39%	144,000
02/10/26	HK$0.2160	-4.85%	342,000

Delayed Quote Hong Kong S.E.

More quotes

Market Closed - Hong Kong S.E. 09:08:17 08/10/2026 BST			5-day change	1st Jan Change
0.2160 ^HKD	+6.93%		-4.85%	-18.49%

09-21	Meilleure Health to Acquire Property Investment Company	MT
09-20	Meilleure Health International Industry Group Limited agreed to acquire Tech-Medi Development Limited from Zhou Xuzhou for HKD 35.2 million.	CI

Market Cap	819M 104M 93.26M 87.01M 79.03M 149M 10.1B 150M 1.05B 408M 5.14B 392M 383M 16.51B	P/E 2024	36.7x	P/E 2025	28.5x
Enterprise Value	1.19B 151M 135M 126M 115M 216M 14.63B 217M 1.52B 592M 7.44B 568M 556M 23.92B	EV / Sales 2024	28.8x	EV / Sales 2025	39.6x
Free-Float	30.87%	Yield 2024	1.38%	Yield 2025	2.08%

09-21	Meilleure Health to Acquire Property Investment Company	MT
09-20	Meilleure Health International Industry Group Limited agreed to acquire Tech-Medi Development Limited from Zhou Xuzhou for HKD 35.2 million.	CI
08-27	Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-27	Meilleure Health International Industry Group Limited Announces Interim (Semi-Annual) Ordinary Cash Dividend for the Six Months Ended 30 June 2026, Payable on 30 September 2026	CI
07-22	Meilleure Health International Industry Group Limited Announces Change of Registered Office Address in Hamilton	CI
07-07	Meilleure Health Forecasts Rise in H1 Profit	MT
07-07	Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2026	CI
06-26	Meilleure Health International Industry Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2025	CI
03-27	Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Meilleure Health International Industry Group Limited Recommends Payment of Final Dividend for the Year Ended December 31, 2025, Payable on August 28, 2026	CI
01-09	Meilleure Health to Acquire Chinese Property Leasing Firm for HK$137 Million	MT
01-08	Meilleure Health International Industry to buy Jiangsu Yide for RMB124.8 million	RE
01-07	Meilleure Health International Industry Group Limited signed a Equity Interest Transfer Agreement to acquire Jiangsu Yide Investment Company Limited from Zhou Chuan and Tan Wensheng for approximately CNY 120 million.	CI

22/04/21	Meilleure Health International Industry : GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; RE-ELECTION OF DIRECTORS; CLOSURE OF REGISTER OF MEMBERS; AND NOTICE OF ANNUAL GENERAL MEETING	PU
22/04/21	PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 24 JUNE 2021 AT 11:00 A.M. AND ANY ADJOURNMENT THEREOF	PU
15/09/20	Meilleure Health International Industry : (1) REVISION OF ANNUAL CAP OF CONTINUING CONNECTED TRANSACTIONS FOR THE YEAR ENDING 31 DECEMBER 2020; AND (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO RENEWAL OF FRAMEWORK AGREEMENT	PU
16/08/20	Meilleure Health International Industry : INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020	PU
15/03/20	Meilleure Health International Industry : PROFIT WARNING	PU

Meilleure Health International Industry Group Limited Share Price

Stocks

2327

BMG5975D1048

Pharmaceuticals

Valuation: Meilleure Health International Industry Group Limited

Chart: Meilleure Health International Industry Group Limited

Latest news: Meilleure Health International Industry Group Limited

Press Releases: Meilleure Health International Industry Group Limited

Quotes and Performance

Price Extremes

Managers and Directors: Meilleure Health International Industry Group Limited

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 day	+6.93%
1 week	-4.85%
Current month	-4.85%
1 month	-9.62%
3 months	-13.60%
6 months	-15.29%
Current year	-18.49%

1 week	0.21	0.22
1 month	0.2	0.24
Current year	0.2	0.3
1 year	0.2	0.3
3 years	0.11	0.32
5 years	0.11	0.48
10 years	0.11	1.64

Manager	Title	Age	Since
Wen Chuan Zhou CEO	Chief Executive Officer	43	29/08/2013
Kwai Kwan Tsoi SEC	Corporate Secretary	34	30/12/2025
Mei Yi Chu SEC	Corporate Secretary	33	30/12/2025

Director	Title	Age	Since
Xu Zhou Zhou CHM	Chairman	70	29/08/2013
Wen Chuan Zhou BRD	Director/Board Member	43	29/08/2013
Chi Wai Chau BRD	Director/Board Member	64	29/08/2013

Date	Insider	Type	Main position	Quantity	% Market Cap.
11/09/26	Xu Zhou Zhou	Other	Chairman	840,000	0.0207%
14/07/26	Xu Zhou Zhou	Other	Chairman	780,000	0.0192%
08/07/26	Wen Chuan Zhou	Other	Chief Executive Officer	240,000	0.0059%

	2024	2025
Net sales	50.68M 6.46M 5.77M 5.38M 4.89M 9.21M 625M 9.28M 64.68M 25.27M 318M 24.24M 23.72M 1.02B	36.52M 4.65M 4.16M 3.88M 3.52M 6.64M 450M 6.68M 46.61M 18.21M 229M 17.47M 17.09M 736M
Net income	32.48M 4.14M 3.7M 3.45M 3.13M 5.9M 400M 5.95M 41.46M 16.2M 204M 15.54M 15.2M 655M	37.98M 4.84M 4.32M 4.03M 3.66M 6.9M 468M 6.95M 48.48M 18.94M 238M 18.17M 17.78M 765M
Net Debt	273M 34.8M 31.09M 29.01M 26.35M 49.63M 3.37B 50M 349M 136M 1.71B 131M 128M 5.5B	368M 46.87M 41.88M 39.07M 35.49M 66.84M 4.53B 67.34M 470M 183M 2.31B 176M 172M 7.41B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED	+6.93%	-4.85%	-24.21%	-22.86%	104M
ELI LILLY AND COMPANY	+2.70%	+2.73%	+40.91%	+110.31%	1,060B
JOHNSON & JOHNSON	+1.44%	-2.38%	+36.83%	+63.95%	623B
ABBVIE INC.	+1.75%	+3.73%	+16.55%	+83.05%	480B
MERCK & CO., INC.	+0.60%	-1.73%	+62.98%	+37.46%	352B
ROCHE HOLDING AG	-1.86%	+1.23%	+21.28%	+40.84%	345B
NOVARTIS AG	-1.47%	+0.22%	+11.10%	+34.26%	274B
ASTRAZENECA PLC	-1.20%	-1.99%	-5.82%	+10.87%	249B
AMGEN INC.	+2.60%	-2.00%	+39.77%	+54.44%	223B
GILEAD SCIENCES, INC.	+1.82%	-1.48%	+25.75%	+96.48%	182B
Average	+0.44%	-1.54%	+22.51%	+50.88%	378.81B
Weighted average by Cap.	-0.27%	+0.04%	+31.39%	+70.13%